| 1 |
Triadafilopoulos G Endoscopic Non-ablative radiofrequency treatment（Stretta） for gastroesophageal reflux disease （GERD） ［J］. Curr Gastroenterol Rep , 2024, 26（4）： 93-98.
|
| 2 |
Zuluaga Arbeláez N, Hani A, Espinoza-Ríos J. ［Approach to refractory gastroesophageal reflux disease］［J］. Rev Gastroenterol Peru, 2024,44（1）：41-51.
|
| 3 |
Lei WY, Yi CH, Liu TT, et al. Esophageal motor abnormalities in gastroesophageal reflux disorders［J］. Tzu Chi Med J, 2024, 36（2）：120-126.
|
| 4 |
Fuchs HF, Gutschow CA, Brinkmann S, et al. Effect of laparoscopic antireflux surgery on esophageal motility［J］. Dig Surg, 2014, 31（4-5）：354-358.
|
| 5 |
Liu L, Li S, Zhu K, et al. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification［J］. Medicine （Baltimore）, 2019, 98（19）： e15543.
|
| 6 |
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0［J］. Neurogastroenterol Motil,2015, 27（2）：160-174.
|
| 7 |
Pandolfino JE, Kahrilas PJ, American gastroenterological association.AGA technical review on the clinical use of esophageal manometry［J］.Gastroenterology, 2005, 128（1）： 209-224.
|
| 8 |
Dhawan I, O'Connell B, Patel A, et al. Utility of esophageal highresolution manometry in clinical practice： first, do HRM［J］. Dig Dis Sci, 2018, 63（12）： 3178-3186.
|
| 9 |
Roman S, Huot L, Zerbib F, et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia： a randomized multicenter study［J］. Am J Gastroenterol, 2016, 111（3）： 372-380.
|
| 10 |
Kostic SV, Rice TW, Baker ME, et al. Timed barium esophagogram：a simple physiologic assessment for achalasia［J］. J Thorac Cardiovasc Surg, 2000, 120（5）： 935-943.
|
| 11 |
Blonski W, Kumar A, Feldman J, et al. Timed barium swallow：diagnostic role and predictive value in untreated achalasia,esophagogastric junction outflow obstruction, and non-achalasia dysphagia［J］. Am J Gastroenterol, 2018, 113（2）：196-203.
|
| 12 |
Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline： diagnosis and management of achalasia［J］. Am J Gastroenterol, 2013, 108（8）：1238-1249； quiz 1250.
|
| 13 |
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease［J］. Am J Gastroenterol, 2013, 108（3）：308-328； quiz 329.
|
| 14 |
Tariq H, Makker J, Ahmed R, et al. Frequent sips of the water for the management of gastroesophageal reflux induced refractory cough： a case report and review of the literature［J］. Case Rep Gastrointest Med,2019, 2019： 9205259..
|
| 15 |
Kumar D, Zifan A, Mittal RK. Botox injection into the lower esophageal sphincter induces hiatal paralysis and gastroesophageal reflux［J］. Am J Physiol Gastrointest Liver Physiol, 2020, 318（1）：G77-G83.
|
| 16 |
Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia［J］. Ann Surg, 2004, 239（3）： 364-370.
|
| 17 |
Lei W, Hung J, Liu T, et al. Influence of prucalopride on esophageal secondary peristalsis in reflux patients with ineffective motility［J］. J Gastroenterol Hepatol, 2018, 33（3）： 650-655.
|
| 18 |
Foocharoen C, Chunlertrith K, Mairiang P, et al. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis： randomized placebo-controlled trial［J］. Rheumatology, 2017,56（2）： 214-222.
|
| 19 |
Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia： a randomized clinical trial［J］. JAMA, 2019, 322（2）： 134-144.
|
| 20 |
Sloan JA, Triggs JR, Pandolfino JE, et al. Treatment experience with a novel 30-mm hydrostatic balloon in esophageal dysmotility： a multicenter retrospective analysis［J］. Gastrointest Endosc, 2020, 92（6）：1251-1257.
|
| 21 |
Schuitenmaker JM, van Hoeij FB, Schijven MP, et al. Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial［J］. Gut, 2022,71（1）： 10-15.
|
| 22 |
Desai N, Kline M, Duncan D, et al. Expanding the role of pneumatic dilation for nonachalasia patients： a comparative study［J］. Gastrointest Endosc, 2023, 97（2）： 251-259.
|
| 23 |
Shejal AH, Ramachandran TM, Kumar NS. Clinical outcome of pneumatic dilatation in patients with achalasia cardia： a single-center prospective study［J］. J Dig Endosc, 2017, 8： 182-186.
|
| 24 |
Elliott TR, Wu PI, Fuentealba S, et al. Long-term outcome following pneumatic dilatation as initial therapy for idiopathic achalasia： an 18-year single-centre experience［J］. Aliment Pharmacol Ther, 2013,37（12）： 1210-1219.
|
| 25 |
Müller M, Keck C, Eckardt AJ, et al. Outcomes of pneumatic dilation in achalasia： extended follow-up of more than 25 years with a focus on manometric subtypes［J］. J Gastroenterol, 2018, 33（5）： 1067-1074.
|
| 26 |
Katzka DA, Castell DO. Review article： an analysis of the efficacy,perforation rates and methods used in pneumatic dilation for achalasia：Review： pneumatic dilation for achalasia［J］. Aliment Pharmacol Ther,2011, 34（8）：832-839.
|
| 27 |
Illés A, Farkas N, Hegyi P, et al. Is Heller myotomy better than balloon dilation？ A meta-analysis［J］. J Gastrointest Liver Dis, 2017, 26（2）：121-127
|
| 28 |
Salvador R, Costantini M, Zaninotto G, et al. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia［J］. J Gastrointest Surg, 2010, 14（11）：1635-1645.
|
| 29 |
Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype［J］. Gastroenterology, 2013,144（4）：718-725； quiz e13-e14.
|
| 30 |
Ichkhanian Y, Sanaei O, Canakis A, et al. Esophageal peroral endoscopic myotomy （POEM） for treatment of esophagogastric junction outflow obstruction： results from the first prospective trial［J］.Endosc Int Open, 2020, 8（9）： E1137-E1143.
|
| 31 |
Von Renteln D, Fuchs K, Fockens P, et al. Peroral endoscopic myotomy for the treatment of achalasia： an international prospective multicenter study［J］. Gastroenterology, 2013, 145（2）：309-311.e1-3.
|
| 32 |
Khaiser A, Baig M, Forcione D, et al. Efficacy and safety of peroral endoscopic myotomy （POEM） in achalasia： an updated metaanalysis［J］. Middle East J Dig Dis, 2023, 15（4）：235-241.
|
| 33 |
Huang Z, Cui Y, Li Y, et al. Peroral endoscopic myotomy for patients with achalasia with previous Heller myotomy： a systematic review and meta-analysis［J］.Gastrointest Endosc, 2021, 93（1）： 47-56.e5.
|
| 34 |
Schwameis K, Oh D, Green KM, et al. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn［J］. Dis Esophagus, 2020, 33（4）： doz099.
|
| 35 |
Kent MS, Luketich JD, Irshad K, et al. Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma［J］. Ann Thorac Surg, 2007, 84（5）： 1710-1715； discussion 1715-1716.
|
| 36 |
Goldberg MB, Abbas AE, Smith MS, et al. Minimally invasive fundoplication is safe and effective in patients with severe esophageal hypomotility［J］. Innovations （Phila）, 2016, 11（6）： 396-399.
|
| 37 |
Wong HJ, Vierra M, Hedberg M, et al. A tailored approach to laparoscopic fundoplication： outcomes in patients with esophageal dysmotility［J］. J Gastrointest Surg, 2022, 26（12）： 2426-2433
|
| 38 |
Strate U, Emmermann A, Fibbe C, et al. Laparoscopic fundoplication：Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility［J］.Surg Endosc, 2008, 22（1）：21-30.
|
| 39 |
Yan J, Strong AT, Sharma G, et al. Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis［J］.Surg Endosc, 2018, 32（9）： 3855-3860.
|
| 40 |
Testoni PA, Vailati C, Testoni S, et al. Transoral incisionless fundoplication （TIF 2.0） with EsophyX for gastroesophageal reflux disease： long-term results and findings affecting outcome［J］. Surg Endosc, 2012, 26（5）： 1425-1435.
|
| 41 |
Zhang B, Hu Y, Shi X, et al. Integrative effects and vagal mechanisms of transcutaneous electrical acustimulation on gastroesophageal motility in patients with gastroesophageal reflux disease［J］. Am J Gastroenterol, 2021, 116（7）： 1495-1505.
|
| 42 |
Paireder M, Kristo I, Asari R, et al. Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility—a safety and efficacy study［J］. Surg Endosc,2019, 33（11）：3623-3628.
|
| 43 |
Ayazi S, Schwameis K, Zheng P, et al. The impact of magnetic sphincter augmentation （MSA） on esophagogastric junction （EGJ） and esophageal body physiology and manometric characteristics［J］. Ann Surg, 2023, 277（3）： e545-e551.
|
| 44 |
Ferrari D, Siboni S, Riva CG, et al. Magnetic sphincter augmentation outcomes in severe gastroesophageal reflux disease［J］.Front Med（Lausanne）, 2021, 8： 645592.
|
| 45 |
Ayazi S, Schwameis K, Zheng P, et al. The impact of magnetic sphincter augmentation （MSA） on esophagogastric junction （EGJ） and esophageal body physiology and manometric characteristics［J］. Ann Surg, 2023, 277（3）： e545-e551.
|